Shin Nippon Biomedical Laboratories, Ltd.
Symbol: 2395.T
JPX
1392
JPYDzisiejsza cena rynkowa
10.3343
Wskaźnik P/E
-0.0844
Wskaźnik PEG
57.95B
Kapitalizacja MRK
- 0.04%
Rentowność DIV
Shin Nippon Biomedical Laboratories, Ltd. (2395-T) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 10533.1 | 6997 | 7286.5 | |||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | -423.6 | 368.1 | 55.8 | |||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 4760.4 | 3501.6 | 2954.1 | |||||||||||||||||||
balance-sheet.row.inventory | 0 | 7329.4 | 4359.4 | 4071.4 | |||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 1276.7 | 1276.5 | 468.1 | |||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 23899.6 | 16134.5 | 14780 | |||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 18879.3 | 13155.8 | 12898 | |||||||||||||||||||
balance-sheet.row.goodwill | 0 | 1438.8 | 0.3 | 0.8 | |||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 260.7 | 212 | 213 | |||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1699.4 | 212.3 | 213.8 | |||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 12404 | 8645 | 8522 | |||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 325.8 | 1129.6 | 521.6 | |||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 34.2 | 35.4 | 37 | |||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 33342.6 | 23178.2 | 22192.4 | |||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-assets | 0 | 57242.2 | 39312.7 | 36972.4 | |||||||||||||||||||
balance-sheet.row.account-payables | 0 | 419.8 | 64.6 | 95 | |||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 8923.2 | 2942.7 | 3486.8 | |||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 603.7 | 743.1 | 683.2 | |||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 9837.5 | 6195.6 | 9199.2 | |||||||||||||||||||
Deferred Revenue Non Current | 0 | -1064 | -68.2 | -642.4 | |||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 3009.8 | 2685.1 | 2317.4 | |||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 9871.5 | 6215.6 | 9217.8 | |||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 357 | 385.8 | 529.3 | |||||||||||||||||||
balance-sheet.row.total-liab | 0 | 30883.2 | 19589.5 | 21133.6 | |||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 2620.8 | 105.7 | |||||||||||||||||||
balance-sheet.row.common-stock | 0 | 9679.1 | 9679.1 | 9679.1 | |||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 13766.2 | 10196.3 | 3854.5 | |||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 460.2 | -2620.8 | -105.7 | |||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2306.4 | -314.3 | 2200.9 | |||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 26211.8 | 19561.1 | 15734.5 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 57242.2 | 39312.7 | 36972.4 | |||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 147.2 | 162 | 104.3 | |||||||||||||||||||
balance-sheet.row.total-equity | 0 | 26359 | 19723.1 | 15838.8 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||
Total Investments | 0 | 11980.4 | 7080.1 | 8286.9 | |||||||||||||||||||
balance-sheet.row.total-debt | 0 | 18760.7 | 9138.3 | 12686.1 | |||||||||||||||||||
balance-sheet.row.net-debt | 0 | 8227.6 | 2509.4 | 5455.3 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 7759.6 | 8183.3 | 4175.6 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1600.5 | 1177.4 | 1187.7 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -2812.9 | 723.3 | 532 | |||||||||||||||||||
cash-flows.row.account-receivables | 0 | -937 | -480 | -343 | |||||||||||||||||||
cash-flows.row.inventory | 0 | -968.5 | -371.1 | -71.7 | |||||||||||||||||||
cash-flows.row.account-payables | 0 | -268.2 | -36.7 | -24.2 | |||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -639.2 | 1611.1 | 970.8 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -2543.2 | -4131.3 | -1148.5 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -4955.7 | -1614.3 | -1118 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -1937.2 | 1200.8 | 1242.3 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -1514.3 | -4194.1 | -895 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 2532.2 | 266.7 | 91.4 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | -55.5 | 72.3 | 410.6 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -5930.6 | -4268.5 | -268.7 | |||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -5468.1 | -3492.3 | -4598.2 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0.2 | 0 | 0 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -0.2 | 0 | 0 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -2484.4 | -826.5 | -206.2 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 14218.8 | -593.1 | 2333.4 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 6266.2 | -4912 | -2471.1 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 311.5 | 496.7 | 29.6 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 4648.9 | -2731 | 2036.6 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 9197.7 | 4548.8 | 7279.8 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 4548.8 | 7279.8 | 5243.3 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 4004 | 5952.8 | 4746.7 | |||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -4955.7 | -1614.3 | -1118 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -951.7 | 4338.5 | 3628.7 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 25090.9 | 17748.5 | 15110.5 | |||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 12044.2 | 8061.2 | 7556.1 | |||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 13046.7 | 9687.3 | 7554.4 | |||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 15.2 | 191.1 | 211.4 | |||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 7801.4 | 5491.7 | 5024.9 | |||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 19845.7 | 13552.9 | 12581 | |||||||||||||||||||
income-statement-row.row.interest-income | 0 | 57.4 | 8.3 | 3 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 125.1 | 126.6 | 184.9 | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 2514 | 3986 | 1644 | |||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 15.2 | 191.1 | 211.4 | |||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 2514 | 3986 | 1644 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 125.1 | 126.6 | 184.9 | |||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1600.5 | 1177.4 | 1187.7 | |||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.operating-income | 0 | 5245.2 | 4195.6 | 2529.5 | |||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 7759.6 | 8183.3 | 4175.6 | |||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 1708.9 | 1016.2 | 497.8 | |||||||||||||||||||
income-statement-row.row.net-income | 0 | 6060.1 | 7127.6 | 3661.9 |
Często zadawane pytania
Ile wynosi Shin Nippon Biomedical Laboratories, Ltd. (2395.T) aktywów ogółem?
Shin Nippon Biomedical Laboratories, Ltd. (2395.T) całkowite aktywa to 57242205000.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to N/A.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.522.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 85.787.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.206.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.150.
Co to jest Shin Nippon Biomedical Laboratories, Ltd. (2395.T) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 6060057000.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 18760662000.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 7801426000.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 0.000.